Previous 10 | Next 10 |
3 Penny Stocks To Watch Right Now The stock market saw something it hasn’t in quite some time: a full halt. At the open today, the S&P opened roughly 7% lower than its previous closing price on Friday. This triggered a circuit breaker halt for 15 minutes. This is a safeguard against...
Gainers: Spherix (NASDAQ: SPEX ) +146% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., LightPath Technologies, Inc., Stocks on the move, , Read more ...
I am a retired medical device executive that now spends my days trying to find companies with a compelling business thesis to invest in. Back in the spring of 2016 I became very intrigued in the emerging field of regenerative medicine. At the time there were about 600 organizations developin...
Athersys (NASDAQ: ATHX) was featured in a recent Institutional Research Report published by Dawson James Securities Inc. The report reads, “Acute respiratory distress syndrome (‘ARDS’) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. Sever...
Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2019 financial results at approximately 4:00 PM Eastern Time on Monday, March 16, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Members of the management team will host the call a...
Stock option award offered as inducement to Ivor Macleod, new Chief Financial Officer of Athersys Athersys, Inc. (“Athersys” or the “Company”) (NASDAQ: ATHX) announced today that, as previously disclosed in its Form 8-K filed with the Securities and Exchange...
Athersys (NASDAQ: ATHX ) appoints Mr. Ivor Macleod, CPA, MBA as Chief Financial Officer (CFO), effective as of January 31. More news on: Athersys, Inc., Healthcare stocks news, Read more ...
CLEVELAND, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the addition of Mr. Ivor Macleod, CPA, MBA, a highly experienced pharmaceutical executive, to the Athersys leadership team. Mr. Macleod has been appointed Chief Financial Officer, effective as of Janu...
RTI Surgical Holdings (NASDAQ: RTIX ) +105% on sale of OEM business . More news on: RTI Surgical Holdings, Inc., TransEnterix, Inc., XBiotech Inc., Stocks on the move, , Read more ...
CLEVELAND, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the one-year follow-up summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell therapy to treat patients who are suffering from acute respiratory ...
News, Short Squeeze, Breakout and More Instantly...
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care indications, announces it has entered into a warrant exercise inducement offer letter to ra...